indwelling subcutaneous cannulas

Product Name:
Country: Canada (CA)

Institute of Health Economics

Outcome Measure

a. Safety: Safety outcomes, including adverse events (diabetic ketoacidosis, severe hypoglycaemia)or complications (infections, pump malfunction);<br>b. efficacy and effectiveness outcomes include glycaemic control (e.g., glycosylated haemoglobin), patient satisfaction and quality of life, secondary complications of diabetes, neuro-cognitive function and behaviour changes in children if applicable, pregnancy outcomes if applicable (p. 48)

Body Classification

Endocrine System

Device Type

Delivery device

Device Category

Treatment of disease

Risk Classification

IIb

Indication

Diabetes mellitus

ICD-10

E10

Feedback